Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Gold ETF median (5 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 19 Dec 2023 – 20 Aug 2026, limited by Baroda BNP Paribas Gold ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Baroda BNP Paribas Gold ETF | Gold |
|---|---|---|
| 19 Dec 2023 | ₹100.00 | ₹100.00 |
| 09 Mar 2024 | ₹104.74 | ₹105.42 |
| 30 May 2024 | ₹115.10 | ₹115.50 |
| 19 Aug 2024 | ₹114.21 | ₹114.74 |
| 08 Nov 2024 | ₹123.08 | ₹123.60 |
| 28 Jan 2025 | ₹127.57 | ₹128.50 |
| 20 Apr 2025 | ₹150.19 | ₹151.23 |
| 10 Jul 2025 | ₹152.92 | ₹153.47 |
| 29 Sep 2025 | ₹177.95 | ₹182.35 |
| 19 Dec 2025 | ₹206.06 | ₹208.82 |
| 11 Mar 2026 | ₹250.06 | ₹252.35 |
| 31 May 2026 | ₹243.29 | ₹244.63 |
| 20 Aug 2026 | ₹243.96 | ₹245.07 |
| Metric | Baroda BNP Paribas · Regular NAV ₹150.76 Moderately High risk ★★★☆☆ 1Y CAT | Category median Gold ETF · 5 funds |
|---|---|---|
| +56.69% | +57.05% | |
| — | +37.53% | |
| — | +25.94% | |
| — | +16.03% | |
| +39.67% | +14.95% | |
| +42.53% | — | |
| — | +10.18% | |
| — | +8.90% | |
| — | +8.86% | |
| Risk | ||
| 19.64% | 19.64% | |
| 2.56 | 1.63 | |
| 3.65 | 2.41 | |
| -22.18% | -22.18% | |
| Gold | — | |
| -1.31% | -1.65% | |
| 1.05 | 1.07 | |
| 98.9% | 99.7% | |
| 95.7% | 98.4% | |
| 0.59% | 0.50% | |
| ₹334.50Cr | ₹334.50Cr | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| Gurvinder Singh Wasan | — | |
| 19 Dec 2023 | — | |
| — | — | |
| — | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.